Celyad Oncology SA
XBRU:CYAD
Celyad Oncology SA
XBRU:CYAD
Price:
0.319
EUR
0.31%
Market Closed
Market Cap:
€14.3m
Cash Flow Statement
Cash Flow Statement
Celyad Oncology SA
Celyad Oncology SA
Currency: EUR
| Jun-2017 | Dec-2017 | Jun-2018 | Dec-2018 | Jun-2019 | Dec-2019 | Jun-2020 | Dec-2020 | Jun-2021 | Dec-2021 | Jun-2022 | Dec-2022 | Jun-2023 | Dec-2023 | Jun-2024 | Dec-2024 | Jun-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||
| Net Income |
(12)
|
(56)
|
(60)
|
(37)
|
(35)
|
(29)
|
(29)
|
(17)
|
(15)
|
(27)
|
(26)
|
(41)
|
(31)
|
(8)
|
(8)
|
(6)
|
(6)
|
|
| Depreciation & Amortization |
1
|
2
|
9
|
1
|
1
|
2
|
2
|
2
|
2
|
2
|
2
|
1
|
1
|
1
|
1
|
0
|
0
|
|
| Stock-Based Compensation |
0
|
3
|
0
|
4
|
0
|
3
|
4
|
3
|
3
|
2
|
2
|
2
|
1
|
1
|
0
|
0
|
0
|
|
| Other Non-Cash Items |
2
|
14
|
9
|
9
|
4
|
(1)
|
1
|
(10)
|
(11)
|
(3)
|
(6)
|
13
|
13
|
(1)
|
0
|
(0)
|
(0)
|
|
| Change in Working Capital |
(3)
|
(3)
|
(1)
|
0
|
0
|
(1)
|
(0)
|
(2)
|
(1)
|
1
|
(1)
|
(2)
|
(4)
|
(6)
|
(3)
|
(0)
|
(0)
|
|
| Cash from Operating Activities |
(13)
N/A
|
(44)
-247%
|
(44)
+1%
|
(27)
+38%
|
(29)
-8%
|
(28)
+4%
|
(27)
+5%
|
(28)
-3%
|
(25)
+9%
|
(27)
-6%
|
(31)
-15%
|
(28)
+9%
|
(20)
+28%
|
(15)
+24%
|
(10)
+38%
|
(6)
+40%
|
(6)
-8%
|
|
| Investing Cash Flow | ||||||||||||||||||
| Capital Expenditures |
(0)
|
(1)
|
(1)
|
(2)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(1)
|
(0)
|
0
|
|
| Other Items |
(11)
|
18
|
40
|
2
|
1
|
10
|
0
|
0
|
0
|
0
|
1
|
7
|
7
|
1
|
0
|
0
|
0
|
|
| Cash from Investing Activities |
(11)
N/A
|
18
N/A
|
39
+121%
|
1
-98%
|
(0)
N/A
|
9
N/A
|
(0)
N/A
|
0
N/A
|
0
-92%
|
(0)
N/A
|
1
N/A
|
7
+550%
|
7
-2%
|
0
-94%
|
(1)
N/A
|
(0)
+85%
|
0
N/A
|
|
| Financing Cash Flow | ||||||||||||||||||
| Net Issuance of Common Stock |
1
|
1
|
43
|
43
|
0
|
16
|
0
|
0
|
8
|
37
|
29
|
0
|
(0)
|
9
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
(0)
|
(0)
|
0
|
0
|
(0)
|
(1)
|
(2)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
(0)
|
(0)
|
(0)
|
|
| Other |
(0)
|
0
|
(0)
|
1
|
2
|
3
|
5
|
7
|
4
|
4
|
4
|
4
|
4
|
0
|
2
|
3
|
1
|
|
| Cash from Financing Activities |
0
N/A
|
1
+803%
|
43
+7 029%
|
44
+2%
|
1
-97%
|
18
+1 477%
|
20
+10%
|
5
-73%
|
11
+95%
|
40
+276%
|
32
-19%
|
3
-90%
|
4
+11%
|
9
+161%
|
12
+24%
|
3
-74%
|
1
-77%
|
|
| Change in Cash | ||||||||||||||||||
| Effect of Foreign Exchange Rates |
0
|
1
|
1
|
0
|
(0)
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
(0)
|
0
|
(0)
|
0
|
(0)
|
(0)
|
|
| Net Change in Cash |
(23)
N/A
|
(25)
-7%
|
39
N/A
|
17
-56%
|
(29)
N/A
|
(1)
+96%
|
(7)
-480%
|
(22)
-217%
|
(15)
+34%
|
13
N/A
|
2
-81%
|
(18)
N/A
|
(9)
+47%
|
(5)
+42%
|
1
N/A
|
(3)
N/A
|
(5)
-94%
|
|
| Free Cash Flow | ||||||||||||||||||
| Free Cash Flow |
(13)
N/A
|
(45)
-252%
|
(45)
+1%
|
(29)
+36%
|
(31)
-6%
|
(29)
+7%
|
(27)
+5%
|
(28)
-3%
|
(26)
+8%
|
(27)
-5%
|
(31)
-15%
|
(28)
+9%
|
(20)
+27%
|
(16)
+21%
|
(10)
+37%
|
(6)
+43%
|
(6)
-6%
|
|
Switch to:
Switch to:
See Also
Discover More
